nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—Salicylamide—Mesalazine—ulcerative colitis	0.271	1	CrCrCtD
Zileuton—PTGS1—ulcerative colitis	0.212	1	CbGaD
Zileuton—ALOX5—Olsalazine—ulcerative colitis	0.11	0.245	CbGbCtD
Zileuton—ALOX5—Balsalazide—ulcerative colitis	0.0984	0.219	CbGbCtD
Zileuton—ALOX5—Mesalazine—ulcerative colitis	0.0787	0.175	CbGbCtD
Zileuton—ALOX5—Sulfasalazine—ulcerative colitis	0.044	0.0977	CbGbCtD
Zileuton—PTGS1—Olsalazine—ulcerative colitis	0.0248	0.0552	CbGbCtD
Zileuton—PTGS1—Balsalazide—ulcerative colitis	0.0221	0.0492	CbGbCtD
Zileuton—PTGS1—Mesalazine—ulcerative colitis	0.0177	0.0393	CbGbCtD
Zileuton—PTGS1—Sulfasalazine—ulcerative colitis	0.00988	0.022	CbGbCtD
Zileuton—CYP3A4—Budesonide—ulcerative colitis	0.00683	0.0152	CbGbCtD
Zileuton—CYP1A2—Nicotine—ulcerative colitis	0.00568	0.0126	CbGbCtD
Zileuton—CYP2C9—Nicotine—ulcerative colitis	0.00512	0.0114	CbGbCtD
Zileuton—CYP2C9—Cholecalciferol—ulcerative colitis	0.00459	0.0102	CbGbCtD
Zileuton—CYP3A4—Methylprednisolone—ulcerative colitis	0.00305	0.00678	CbGbCtD
Zileuton—CYP3A4—Nicotine—ulcerative colitis	0.00297	0.00661	CbGbCtD
Zileuton—CYP3A4—Cholecalciferol—ulcerative colitis	0.00267	0.00593	CbGbCtD
Zileuton—CYP3A4—Triamcinolone—ulcerative colitis	0.00231	0.00514	CbGbCtD
Zileuton—CYP2C9—Dexamethasone—ulcerative colitis	0.00199	0.00441	CbGbCtD
Zileuton—CYP3A4—Betamethasone—ulcerative colitis	0.00198	0.00441	CbGbCtD
Zileuton—CYP3A4—Prednisolone—ulcerative colitis	0.00196	0.00435	CbGbCtD
Zileuton—CYP3A4—Hydrocortisone—ulcerative colitis	0.00186	0.00412	CbGbCtD
Zileuton—CYP3A4—Prednisone—ulcerative colitis	0.00185	0.00411	CbGbCtD
Zileuton—CYP3A4—Dexamethasone—ulcerative colitis	0.00115	0.00257	CbGbCtD
Zileuton—Tiaprofenic acid—PTGS1—ulcerative colitis	0.000846	0.636	CrCbGaD
Zileuton—Tiaprofenic acid—PTGS2—ulcerative colitis	0.000484	0.364	CrCbGaD
Zileuton—LTB4R—lymphoid tissue—ulcerative colitis	0.000479	0.148	CbGeAlD
Zileuton—LTB4R—liver—ulcerative colitis	0.000353	0.109	CbGeAlD
Zileuton—UGT1A9—digestive system—ulcerative colitis	0.000318	0.0984	CbGeAlD
Zileuton—ALOX5—smooth muscle tissue—ulcerative colitis	0.000264	0.0816	CbGeAlD
Zileuton—EPHX2—liver—ulcerative colitis	0.000259	0.0801	CbGeAlD
Zileuton—Abdominal pain upper—Mesalazine—ulcerative colitis	0.000253	0.00593	CcSEcCtD
Zileuton—Discomfort—Nicotine—ulcerative colitis	0.000251	0.00587	CcSEcCtD
Zileuton—Sinusitis—Budesonide—ulcerative colitis	0.000247	0.00577	CcSEcCtD
Zileuton—UGT1A9—liver—ulcerative colitis	0.000237	0.0733	CbGeAlD
Zileuton—Musculoskeletal discomfort—Mercaptopurine—ulcerative colitis	0.000229	0.00535	CcSEcCtD
Zileuton—Upper respiratory tract infection—Mesalazine—ulcerative colitis	0.000223	0.00521	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Nicotine—ulcerative colitis	0.000222	0.00519	CcSEcCtD
Zileuton—Insomnia—Nicotine—ulcerative colitis	0.00022	0.00515	CcSEcCtD
Zileuton—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000217	0.00507	CcSEcCtD
Zileuton—Somnolence—Nicotine—ulcerative colitis	0.000216	0.00506	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000215	0.0109	CbGpPWpGaD
Zileuton—Dyspepsia—Nicotine—ulcerative colitis	0.000214	0.00501	CcSEcCtD
Zileuton—ALOX5—lymphoid tissue—ulcerative colitis	0.000211	0.0652	CbGeAlD
Zileuton—ALOX5—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.00021	0.0107	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.00021	0.00492	CcSEcCtD
Zileuton—ALOX5—digestive system—ulcerative colitis	0.000209	0.0644	CbGeAlD
Zileuton—Jaundice—Mesalazine—ulcerative colitis	0.000208	0.00487	CcSEcCtD
Zileuton—Constipation—Nicotine—ulcerative colitis	0.000208	0.00487	CcSEcCtD
Zileuton—Pain—Nicotine—ulcerative colitis	0.000208	0.00487	CcSEcCtD
Zileuton—Urinary tract infection—Mesalazine—ulcerative colitis	0.000208	0.00486	CcSEcCtD
Zileuton—Conjunctivitis—Mesalazine—ulcerative colitis	0.000208	0.00486	CcSEcCtD
Zileuton—Flatulence—Budesonide—ulcerative colitis	0.000202	0.00473	CcSEcCtD
Zileuton—Tension—Budesonide—ulcerative colitis	0.000202	0.00471	CcSEcCtD
Zileuton—Feeling abnormal—Nicotine—ulcerative colitis	0.000201	0.00469	CcSEcCtD
Zileuton—Sinusitis—Mesalazine—ulcerative colitis	0.000201	0.00469	CcSEcCtD
Zileuton—Nervousness—Budesonide—ulcerative colitis	0.000199	0.00467	CcSEcCtD
Zileuton—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000199	0.00465	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000196	0.00998	CbGpPWpGaD
Zileuton—Urticaria—Nicotine—ulcerative colitis	0.000193	0.00452	CcSEcCtD
Zileuton—LTB4R—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000192	0.00978	CbGpPWpGaD
Zileuton—Body temperature increased—Nicotine—ulcerative colitis	0.000192	0.0045	CcSEcCtD
Zileuton—Hepatitis—Mesalazine—ulcerative colitis	0.000192	0.00449	CcSEcCtD
Zileuton—Ill-defined disorder—Budesonide—ulcerative colitis	0.000191	0.00446	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000189	0.00959	CbGpPWpGaD
Zileuton—Malaise—Budesonide—ulcerative colitis	0.000185	0.00433	CcSEcCtD
Zileuton—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000185	0.00433	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000185	0.00938	CbGpPWpGaD
Zileuton—Abdominal pain upper—Hydrocortisone—ulcerative colitis	0.00018	0.00421	CcSEcCtD
Zileuton—Hypersensitivity—Nicotine—ulcerative colitis	0.000179	0.0042	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—CRP—ulcerative colitis	0.000178	0.00904	CbGpPWpGaD
Zileuton—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000176	0.00895	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000175	0.00889	CbGpPWpGaD
Zileuton—Chest pain—Budesonide—ulcerative colitis	0.000175	0.00409	CcSEcCtD
Zileuton—Myalgia—Budesonide—ulcerative colitis	0.000175	0.00409	CcSEcCtD
Zileuton—Arthralgia—Budesonide—ulcerative colitis	0.000175	0.00409	CcSEcCtD
Zileuton—Discomfort—Budesonide—ulcerative colitis	0.000173	0.00404	CcSEcCtD
Zileuton—Pruritus—Nicotine—ulcerative colitis	0.000172	0.00403	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000172	0.00875	CbGpPWpGaD
Zileuton—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000172	0.00402	CcSEcCtD
Zileuton—Ill-defined disorder—Azathioprine—ulcerative colitis	0.00017	0.00398	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000168	0.00855	CbGpPWpGaD
Zileuton—Diarrhoea—Nicotine—ulcerative colitis	0.000167	0.0039	CcSEcCtD
Zileuton—Malaise—Azathioprine—ulcerative colitis	0.000165	0.00387	CcSEcCtD
Zileuton—Flatulence—Mesalazine—ulcerative colitis	0.000165	0.00385	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TLR4—ulcerative colitis	0.000164	0.00833	CbGpPWpGaD
Zileuton—Tension—Mesalazine—ulcerative colitis	0.000164	0.00383	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCR1—ulcerative colitis	0.000164	0.00832	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000162	0.00826	CbGpPWpGaD
Zileuton—Nervousness—Mesalazine—ulcerative colitis	0.000162	0.0038	CcSEcCtD
Zileuton—Dizziness—Nicotine—ulcerative colitis	0.000161	0.00377	CcSEcCtD
Zileuton—Vomiting—Mercaptopurine—ulcerative colitis	0.00016	0.00374	CcSEcCtD
Zileuton—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.000158	0.00371	CcSEcCtD
Zileuton—Rash—Mercaptopurine—ulcerative colitis	0.000158	0.0037	CcSEcCtD
Zileuton—Dermatitis—Mercaptopurine—ulcerative colitis	0.000158	0.0037	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000158	0.00804	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—ICAM1—ulcerative colitis	0.000157	0.00799	CbGpPWpGaD
Zileuton—Myalgia—Azathioprine—ulcerative colitis	0.000156	0.00365	CcSEcCtD
Zileuton—Arthralgia—Azathioprine—ulcerative colitis	0.000156	0.00365	CcSEcCtD
Zileuton—ALOX5—liver—ulcerative colitis	0.000155	0.048	CbGeAlD
Zileuton—Ill-defined disorder—Mesalazine—ulcerative colitis	0.000155	0.00363	CcSEcCtD
Zileuton—Vomiting—Nicotine—ulcerative colitis	0.000155	0.00362	CcSEcCtD
Zileuton—Discomfort—Azathioprine—ulcerative colitis	0.000154	0.00361	CcSEcCtD
Zileuton—Rash—Nicotine—ulcerative colitis	0.000153	0.00359	CcSEcCtD
Zileuton—Dermatitis—Nicotine—ulcerative colitis	0.000153	0.00359	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000153	0.00357	CcSEcCtD
Zileuton—Headache—Nicotine—ulcerative colitis	0.000152	0.00357	CcSEcCtD
Zileuton—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—ulcerative colitis	0.000152	0.00774	CbGpPWpGaD
Zileuton—Insomnia—Budesonide—ulcerative colitis	0.000152	0.00355	CcSEcCtD
Zileuton—Conjunctivitis—Prednisolone—ulcerative colitis	0.000151	0.00354	CcSEcCtD
Zileuton—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000151	0.00767	CbGpPWpGaD
Zileuton—Malaise—Mesalazine—ulcerative colitis	0.000151	0.00352	CcSEcCtD
Zileuton—Nausea—Mercaptopurine—ulcerative colitis	0.000149	0.00349	CcSEcCtD
Zileuton—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000149	0.00349	CcSEcCtD
Zileuton—Somnolence—Budesonide—ulcerative colitis	0.000149	0.00349	CcSEcCtD
Zileuton—Dyspepsia—Budesonide—ulcerative colitis	0.000148	0.00345	CcSEcCtD
Zileuton—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000145	0.00339	CcSEcCtD
Zileuton—Nausea—Nicotine—ulcerative colitis	0.000145	0.00338	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL20—ulcerative colitis	0.000144	0.0073	CbGpPWpGaD
Zileuton—Pain—Budesonide—ulcerative colitis	0.000143	0.00335	CcSEcCtD
Zileuton—Constipation—Budesonide—ulcerative colitis	0.000143	0.00335	CcSEcCtD
Zileuton—Arthralgia—Mesalazine—ulcerative colitis	0.000142	0.00333	CcSEcCtD
Zileuton—Myalgia—Mesalazine—ulcerative colitis	0.000142	0.00333	CcSEcCtD
Zileuton—Chest pain—Mesalazine—ulcerative colitis	0.000142	0.00333	CcSEcCtD
Zileuton—Discomfort—Mesalazine—ulcerative colitis	0.00014	0.00329	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000139	0.00708	CbGpPWpGaD
Zileuton—Conjunctivitis—Triamcinolone—ulcerative colitis	0.000139	0.00325	CcSEcCtD
Zileuton—Feeling abnormal—Budesonide—ulcerative colitis	0.000138	0.00323	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000136	0.00319	CcSEcCtD
Zileuton—Urticaria—Budesonide—ulcerative colitis	0.000133	0.00312	CcSEcCtD
Zileuton—Body temperature increased—Budesonide—ulcerative colitis	0.000132	0.0031	CcSEcCtD
Zileuton—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000129	0.00302	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCR2—ulcerative colitis	0.000128	0.00651	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000127	0.00648	CbGpPWpGaD
Zileuton—ALOX5—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000127	0.00644	CbGpPWpGaD
Zileuton—Conjunctivitis—Betamethasone—ulcerative colitis	0.000126	0.00295	CcSEcCtD
Zileuton—Conjunctivitis—Dexamethasone—ulcerative colitis	0.000126	0.00295	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000124	0.00291	CcSEcCtD
Zileuton—Hypersensitivity—Budesonide—ulcerative colitis	0.000123	0.00289	CcSEcCtD
Zileuton—Feeling abnormal—Azathioprine—ulcerative colitis	0.000123	0.00289	CcSEcCtD
Zileuton—Insomnia—Mesalazine—ulcerative colitis	0.000123	0.00288	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000123	0.00626	CbGpPWpGaD
Zileuton—Somnolence—Mesalazine—ulcerative colitis	0.000121	0.00284	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCR6—ulcerative colitis	0.00012	0.00612	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—CRP—ulcerative colitis	0.00012	0.00611	CbGpPWpGaD
Zileuton—Dyspepsia—Mesalazine—ulcerative colitis	0.00012	0.00281	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IFNG—ulcerative colitis	0.00012	0.00608	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—PTGS2—ulcerative colitis	0.000119	0.00606	CbGpPWpGaD
Zileuton—Pruritus—Budesonide—ulcerative colitis	0.000119	0.00277	CcSEcCtD
Zileuton—Body temperature increased—Azathioprine—ulcerative colitis	0.000118	0.00277	CcSEcCtD
Zileuton—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000118	0.00275	CcSEcCtD
Zileuton—Pain—Mesalazine—ulcerative colitis	0.000117	0.00273	CcSEcCtD
Zileuton—Constipation—Mesalazine—ulcerative colitis	0.000117	0.00273	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—CXCL8—ulcerative colitis	0.000116	0.00588	CbGpPWpGaD
Zileuton—Diarrhoea—Budesonide—ulcerative colitis	0.000115	0.00268	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—PTGS2—ulcerative colitis	0.000115	0.00583	CbGpPWpGaD
Zileuton—Ill-defined disorder—Prednisolone—ulcerative colitis	0.000113	0.00264	CcSEcCtD
Zileuton—Feeling abnormal—Mesalazine—ulcerative colitis	0.000112	0.00263	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—CXCL8—ulcerative colitis	0.000111	0.00565	CbGpPWpGaD
Zileuton—Dizziness—Budesonide—ulcerative colitis	0.000111	0.00259	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.000111	0.00562	CbGpPWpGaD
Zileuton—Hypersensitivity—Azathioprine—ulcerative colitis	0.00011	0.00258	CcSEcCtD
Zileuton—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.00011	0.00258	CcSEcCtD
Zileuton—PTGS1—epithelium—ulcerative colitis	0.00011	0.034	CbGeAlD
Zileuton—Malaise—Prednisolone—ulcerative colitis	0.00011	0.00257	CcSEcCtD
Zileuton—Urticaria—Mesalazine—ulcerative colitis	0.000108	0.00253	CcSEcCtD
Zileuton—Body temperature increased—Mesalazine—ulcerative colitis	0.000108	0.00252	CcSEcCtD
Zileuton—Malaise—Hydrocortisone—ulcerative colitis	0.000107	0.00251	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IL1B—ulcerative colitis	0.000107	0.00542	CbGpPWpGaD
Zileuton—Vomiting—Budesonide—ulcerative colitis	0.000107	0.00249	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IL2—ulcerative colitis	0.000106	0.0054	CbGpPWpGaD
Zileuton—PTGS1—smooth muscle tissue—ulcerative colitis	0.000106	0.0328	CbGeAlD
Zileuton—LTB4R—GPCR ligand binding—PTGER4—ulcerative colitis	0.000106	0.00539	CbGpPWpGaD
Zileuton—Rash—Budesonide—ulcerative colitis	0.000106	0.00247	CcSEcCtD
Zileuton—Dermatitis—Budesonide—ulcerative colitis	0.000106	0.00247	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000105	0.00536	CbGpPWpGaD
Zileuton—Headache—Budesonide—ulcerative colitis	0.000105	0.00246	CcSEcCtD
Zileuton—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000104	0.00243	CcSEcCtD
Zileuton—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000104	0.00242	CcSEcCtD
Zileuton—Diarrhoea—Azathioprine—ulcerative colitis	0.000102	0.0024	CcSEcCtD
Zileuton—Discomfort—Prednisolone—ulcerative colitis	0.000102	0.00239	CcSEcCtD
Zileuton—Myalgia—Hydrocortisone—ulcerative colitis	0.000101	0.00237	CcSEcCtD
Zileuton—Malaise—Triamcinolone—ulcerative colitis	0.000101	0.00236	CcSEcCtD
Zileuton—Malaise—Methylprednisolone—ulcerative colitis	0.000101	0.00235	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—MMP9—ulcerative colitis	0.000101	0.00511	CbGpPWpGaD
Zileuton—Hypersensitivity—Mesalazine—ulcerative colitis	0.0001	0.00235	CcSEcCtD
Zileuton—Discomfort—Hydrocortisone—ulcerative colitis	9.99e-05	0.00234	CcSEcCtD
Zileuton—Nausea—Budesonide—ulcerative colitis	9.96e-05	0.00233	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—MPO—ulcerative colitis	9.92e-05	0.00504	CbGpPWpGaD
Zileuton—Dizziness—Azathioprine—ulcerative colitis	9.9e-05	0.00232	CcSEcCtD
Zileuton—PTGS1—Eicosanoid Synthesis—PTGS2—ulcerative colitis	9.89e-05	0.00503	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—GHRL—ulcerative colitis	9.71e-05	0.00493	CbGpPWpGaD
Zileuton—CYP1A2—digestive system—ulcerative colitis	9.66e-05	0.0299	CbGeAlD
Zileuton—Pruritus—Mesalazine—ulcerative colitis	9.64e-05	0.00226	CcSEcCtD
Zileuton—Myalgia—Triamcinolone—ulcerative colitis	9.52e-05	0.00223	CcSEcCtD
Zileuton—Vomiting—Azathioprine—ulcerative colitis	9.51e-05	0.00223	CcSEcCtD
Zileuton—Myalgia—Methylprednisolone—ulcerative colitis	9.5e-05	0.00222	CcSEcCtD
Zileuton—Arthralgia—Methylprednisolone—ulcerative colitis	9.5e-05	0.00222	CcSEcCtD
Zileuton—Rash—Azathioprine—ulcerative colitis	9.44e-05	0.00221	CcSEcCtD
Zileuton—Dermatitis—Azathioprine—ulcerative colitis	9.43e-05	0.00221	CcSEcCtD
Zileuton—Ill-defined disorder—Betamethasone—ulcerative colitis	9.41e-05	0.0022	CcSEcCtD
Zileuton—Ill-defined disorder—Dexamethasone—ulcerative colitis	9.41e-05	0.0022	CcSEcCtD
Zileuton—Discomfort—Triamcinolone—ulcerative colitis	9.41e-05	0.0022	CcSEcCtD
Zileuton—Discomfort—Methylprednisolone—ulcerative colitis	9.39e-05	0.0022	CcSEcCtD
Zileuton—Headache—Azathioprine—ulcerative colitis	9.37e-05	0.00219	CcSEcCtD
Zileuton—Diarrhoea—Mesalazine—ulcerative colitis	9.33e-05	0.00218	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CXCR1—ulcerative colitis	9.25e-05	0.0047	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—ALB—ulcerative colitis	9.22e-05	0.00469	CbGpPWpGaD
Zileuton—CYP2C9—digestive system—ulcerative colitis	9.17e-05	0.0283	CbGeAlD
Zileuton—Malaise—Betamethasone—ulcerative colitis	9.15e-05	0.00214	CcSEcCtD
Zileuton—Malaise—Dexamethasone—ulcerative colitis	9.15e-05	0.00214	CcSEcCtD
Zileuton—EPHX2—Metabolism—CHP1—ulcerative colitis	9.07e-05	0.00461	CbGpPWpGaD
Zileuton—Dizziness—Mesalazine—ulcerative colitis	9.01e-05	0.00211	CcSEcCtD
Zileuton—Insomnia—Prednisolone—ulcerative colitis	8.98e-05	0.0021	CcSEcCtD
Zileuton—Nausea—Azathioprine—ulcerative colitis	8.89e-05	0.00208	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	8.83e-05	0.00207	CcSEcCtD
Zileuton—Insomnia—Hydrocortisone—ulcerative colitis	8.77e-05	0.00205	CcSEcCtD
Zileuton—Vomiting—Mesalazine—ulcerative colitis	8.67e-05	0.00203	CcSEcCtD
Zileuton—Myalgia—Betamethasone—ulcerative colitis	8.64e-05	0.00202	CcSEcCtD
Zileuton—Myalgia—Dexamethasone—ulcerative colitis	8.64e-05	0.00202	CcSEcCtD
Zileuton—Rash—Mesalazine—ulcerative colitis	8.59e-05	0.00201	CcSEcCtD
Zileuton—Dermatitis—Mesalazine—ulcerative colitis	8.59e-05	0.00201	CcSEcCtD
Zileuton—Headache—Mesalazine—ulcerative colitis	8.54e-05	0.002	CcSEcCtD
Zileuton—Discomfort—Betamethasone—ulcerative colitis	8.53e-05	0.002	CcSEcCtD
Zileuton—Discomfort—Dexamethasone—ulcerative colitis	8.53e-05	0.002	CcSEcCtD
Zileuton—Dyspepsia—Hydrocortisone—ulcerative colitis	8.53e-05	0.002	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	8.5e-05	0.00432	CbGpPWpGaD
Zileuton—Pain—Prednisolone—ulcerative colitis	8.49e-05	0.00199	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—IFNG—ulcerative colitis	8.41e-05	0.00428	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCR1—ulcerative colitis	8.4e-05	0.00427	CbGpPWpGaD
Zileuton—PTGS1—digestive system—ulcerative colitis	8.37e-05	0.0259	CbGeAlD
Zileuton—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	8.37e-05	0.00196	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	8.32e-05	0.00195	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—RELA—ulcerative colitis	8.3e-05	0.00422	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	8.3e-05	0.00194	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TGFB1—ulcerative colitis	8.29e-05	0.00421	CbGpPWpGaD
Zileuton—Pain—Hydrocortisone—ulcerative colitis	8.29e-05	0.00194	CcSEcCtD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—ulcerative colitis	8.27e-05	0.0042	CbGpPWpGaD
Zileuton—Insomnia—Triamcinolone—ulcerative colitis	8.25e-05	0.00193	CcSEcCtD
Zileuton—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	8.25e-05	0.0042	CbGpPWpGaD
Zileuton—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	8.24e-05	0.00419	CbGpPWpGaD
Zileuton—Insomnia—Methylprednisolone—ulcerative colitis	8.24e-05	0.00193	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisone—ulcerative colitis	8.2e-05	0.00192	CcSEcCtD
Zileuton—Feeling abnormal—Prednisolone—ulcerative colitis	8.18e-05	0.00191	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CCL20—ulcerative colitis	8.12e-05	0.00413	CbGpPWpGaD
Zileuton—Nausea—Mesalazine—ulcerative colitis	8.1e-05	0.00189	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—PTGS2—ulcerative colitis	8.06e-05	0.0041	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—TNF—ulcerative colitis	8.05e-05	0.00409	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—ADRB2—ulcerative colitis	8.03e-05	0.00408	CbGpPWpGaD
Zileuton—Dyspepsia—Triamcinolone—ulcerative colitis	8.03e-05	0.00188	CcSEcCtD
Zileuton—Dyspepsia—Methylprednisolone—ulcerative colitis	8.02e-05	0.00188	CcSEcCtD
Zileuton—Feeling abnormal—Hydrocortisone—ulcerative colitis	7.99e-05	0.00187	CcSEcCtD
Zileuton—Malaise—Prednisone—ulcerative colitis	7.97e-05	0.00186	CcSEcCtD
Zileuton—Urticaria—Prednisolone—ulcerative colitis	7.88e-05	0.00184	CcSEcCtD
Zileuton—EPHX2—Metabolism—DLD—ulcerative colitis	7.83e-05	0.00398	CbGpPWpGaD
Zileuton—Pain—Triamcinolone—ulcerative colitis	7.8e-05	0.00183	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TNF—ulcerative colitis	7.74e-05	0.00393	CbGpPWpGaD
Zileuton—Urticaria—Hydrocortisone—ulcerative colitis	7.7e-05	0.0018	CcSEcCtD
Zileuton—Body temperature increased—Hydrocortisone—ulcerative colitis	7.66e-05	0.00179	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—GNA12—ulcerative colitis	7.63e-05	0.00388	CbGpPWpGaD
Zileuton—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	7.55e-05	0.00384	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	7.54e-05	0.00177	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	7.54e-05	0.00177	CcSEcCtD
Zileuton—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	7.54e-05	0.00383	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	7.54e-05	0.00383	CbGpPWpGaD
Zileuton—Myalgia—Prednisone—ulcerative colitis	7.52e-05	0.00176	CcSEcCtD
Zileuton—Arthralgia—Prednisone—ulcerative colitis	7.52e-05	0.00176	CcSEcCtD
Zileuton—Feeling abnormal—Triamcinolone—ulcerative colitis	7.52e-05	0.00176	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	7.52e-05	0.00382	CbGpPWpGaD
Zileuton—Feeling abnormal—Methylprednisolone—ulcerative colitis	7.5e-05	0.00176	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—IL1B—ulcerative colitis	7.5e-05	0.00381	CbGpPWpGaD
Zileuton—Insomnia—Dexamethasone—ulcerative colitis	7.49e-05	0.00175	CcSEcCtD
Zileuton—Insomnia—Betamethasone—ulcerative colitis	7.49e-05	0.00175	CcSEcCtD
Zileuton—Discomfort—Prednisone—ulcerative colitis	7.43e-05	0.00174	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CCL20—ulcerative colitis	7.37e-05	0.00375	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisolone—ulcerative colitis	7.31e-05	0.00171	CcSEcCtD
Zileuton—Dyspepsia—Betamethasone—ulcerative colitis	7.29e-05	0.00171	CcSEcCtD
Zileuton—Dyspepsia—Dexamethasone—ulcerative colitis	7.29e-05	0.00171	CcSEcCtD
Zileuton—Urticaria—Triamcinolone—ulcerative colitis	7.25e-05	0.0017	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CXCR2—ulcerative colitis	7.24e-05	0.00368	CbGpPWpGaD
Zileuton—Urticaria—Methylprednisolone—ulcerative colitis	7.23e-05	0.00169	CcSEcCtD
Zileuton—Body temperature increased—Triamcinolone—ulcerative colitis	7.21e-05	0.00169	CcSEcCtD
Zileuton—CYP1A2—liver—ulcerative colitis	7.2e-05	0.0222	CbGeAlD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	7.19e-05	0.00365	CbGpPWpGaD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	7.17e-05	0.00365	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	7.15e-05	0.00167	CcSEcCtD
Zileuton—Gastrointestinal disorder—Betamethasone—ulcerative colitis	7.15e-05	0.00167	CcSEcCtD
Zileuton—Hypersensitivity—Hydrocortisone—ulcerative colitis	7.14e-05	0.00167	CcSEcCtD
Zileuton—Pain—Betamethasone—ulcerative colitis	7.08e-05	0.00166	CcSEcCtD
Zileuton—Pain—Dexamethasone—ulcerative colitis	7.08e-05	0.00166	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—NFKB1—ulcerative colitis	7e-05	0.00356	CbGpPWpGaD
Zileuton—CYP3A4—digestive system—ulcerative colitis	6.99e-05	0.0216	CbGeAlD
Zileuton—LTB4R—Signaling by GPCR—GNA12—ulcerative colitis	6.93e-05	0.00352	CbGpPWpGaD
Zileuton—Pruritus—Hydrocortisone—ulcerative colitis	6.86e-05	0.0016	CcSEcCtD
Zileuton—CYP2C9—liver—ulcerative colitis	6.83e-05	0.0211	CbGeAlD
Zileuton—LTB4R—Spinal Cord Injury—TP53—ulcerative colitis	6.82e-05	0.00347	CbGpPWpGaD
Zileuton—Feeling abnormal—Dexamethasone—ulcerative colitis	6.82e-05	0.0016	CcSEcCtD
Zileuton—Feeling abnormal—Betamethasone—ulcerative colitis	6.82e-05	0.0016	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CCR6—ulcerative colitis	6.8e-05	0.00346	CbGpPWpGaD
Zileuton—Hypersensitivity—Triamcinolone—ulcerative colitis	6.72e-05	0.00157	CcSEcCtD
Zileuton—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.71e-05	0.00157	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	6.71e-05	0.00341	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	6.68e-05	0.0034	CbGpPWpGaD
Zileuton—Diarrhoea—Hydrocortisone—ulcerative colitis	6.63e-05	0.00155	CcSEcCtD
Zileuton—Urticaria—Betamethasone—ulcerative colitis	6.58e-05	0.00154	CcSEcCtD
Zileuton—Urticaria—Dexamethasone—ulcerative colitis	6.58e-05	0.00154	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CXCR2—ulcerative colitis	6.57e-05	0.00334	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Prednisone—ulcerative colitis	6.57e-05	0.00154	CcSEcCtD
Zileuton—Dizziness—Prednisolone—ulcerative colitis	6.56e-05	0.00154	CcSEcCtD
Zileuton—UGT1A9—Biological oxidations—PTGS1—ulcerative colitis	6.55e-05	0.00333	CbGpPWpGaD
Zileuton—Body temperature increased—Dexamethasone—ulcerative colitis	6.55e-05	0.00153	CcSEcCtD
Zileuton—Body temperature increased—Betamethasone—ulcerative colitis	6.55e-05	0.00153	CcSEcCtD
Zileuton—Insomnia—Prednisone—ulcerative colitis	6.52e-05	0.00153	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—IL6—ulcerative colitis	6.49e-05	0.0033	CbGpPWpGaD
Zileuton—Pruritus—Triamcinolone—ulcerative colitis	6.46e-05	0.00151	CcSEcCtD
Zileuton—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	6.44e-05	0.00328	CbGpPWpGaD
Zileuton—Pruritus—Methylprednisolone—ulcerative colitis	6.44e-05	0.00151	CcSEcCtD
Zileuton—Dizziness—Hydrocortisone—ulcerative colitis	6.41e-05	0.0015	CcSEcCtD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	6.4e-05	0.00326	CbGpPWpGaD
Zileuton—Dyspepsia—Prednisone—ulcerative colitis	6.35e-05	0.00149	CcSEcCtD
Zileuton—Rash—Prednisolone—ulcerative colitis	6.26e-05	0.00146	CcSEcCtD
Zileuton—Dermatitis—Prednisolone—ulcerative colitis	6.25e-05	0.00146	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IL6—ulcerative colitis	6.25e-05	0.00318	CbGpPWpGaD
Zileuton—Diarrhoea—Methylprednisolone—ulcerative colitis	6.23e-05	0.00146	CcSEcCtD
Zileuton—Headache—Prednisolone—ulcerative colitis	6.22e-05	0.00145	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CCR6—ulcerative colitis	6.18e-05	0.00314	CbGpPWpGaD
Zileuton—Constipation—Prednisone—ulcerative colitis	6.17e-05	0.00144	CcSEcCtD
Zileuton—Vomiting—Hydrocortisone—ulcerative colitis	6.16e-05	0.00144	CcSEcCtD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	6.14e-05	0.00312	CbGpPWpGaD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	6.13e-05	0.00312	CbGpPWpGaD
Zileuton—Rash—Hydrocortisone—ulcerative colitis	6.11e-05	0.00143	CcSEcCtD
Zileuton—Dermatitis—Hydrocortisone—ulcerative colitis	6.11e-05	0.00143	CcSEcCtD
Zileuton—Headache—Hydrocortisone—ulcerative colitis	6.07e-05	0.00142	CcSEcCtD
Zileuton—Dizziness—Triamcinolone—ulcerative colitis	6.04e-05	0.00141	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—SEL1L—ulcerative colitis	6.02e-05	0.00306	CbGpPWpGaD
Zileuton—Dizziness—Methylprednisolone—ulcerative colitis	6.02e-05	0.00141	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—PTGER4—ulcerative colitis	5.99e-05	0.00305	CbGpPWpGaD
Zileuton—Feeling abnormal—Prednisone—ulcerative colitis	5.94e-05	0.00139	CcSEcCtD
Zileuton—Nausea—Prednisolone—ulcerative colitis	5.89e-05	0.00138	CcSEcCtD
Zileuton—Pruritus—Dexamethasone—ulcerative colitis	5.86e-05	0.00137	CcSEcCtD
Zileuton—Pruritus—Betamethasone—ulcerative colitis	5.86e-05	0.00137	CcSEcCtD
Zileuton—Vomiting—Triamcinolone—ulcerative colitis	5.8e-05	0.00136	CcSEcCtD
Zileuton—Vomiting—Methylprednisolone—ulcerative colitis	5.79e-05	0.00135	CcSEcCtD
Zileuton—Nausea—Hydrocortisone—ulcerative colitis	5.76e-05	0.00135	CcSEcCtD
Zileuton—Rash—Triamcinolone—ulcerative colitis	5.75e-05	0.00135	CcSEcCtD
Zileuton—Dermatitis—Triamcinolone—ulcerative colitis	5.75e-05	0.00135	CcSEcCtD
Zileuton—Rash—Methylprednisolone—ulcerative colitis	5.74e-05	0.00134	CcSEcCtD
Zileuton—Dermatitis—Methylprednisolone—ulcerative colitis	5.74e-05	0.00134	CcSEcCtD
Zileuton—Urticaria—Prednisone—ulcerative colitis	5.73e-05	0.00134	CcSEcCtD
Zileuton—Headache—Triamcinolone—ulcerative colitis	5.72e-05	0.00134	CcSEcCtD
Zileuton—Headache—Methylprednisolone—ulcerative colitis	5.7e-05	0.00133	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—ulcerative colitis	5.7e-05	0.00133	CcSEcCtD
Zileuton—Diarrhoea—Betamethasone—ulcerative colitis	5.67e-05	0.00133	CcSEcCtD
Zileuton—Diarrhoea—Dexamethasone—ulcerative colitis	5.67e-05	0.00133	CcSEcCtD
Zileuton—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	5.66e-05	0.00288	CbGpPWpGaD
Zileuton—PTGS1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	5.5e-05	0.00279	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—GHRL—ulcerative colitis	5.48e-05	0.00279	CbGpPWpGaD
Zileuton—Dizziness—Betamethasone—ulcerative colitis	5.48e-05	0.00128	CcSEcCtD
Zileuton—Dizziness—Dexamethasone—ulcerative colitis	5.48e-05	0.00128	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—ulcerative colitis	5.44e-05	0.00277	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PTGER4—ulcerative colitis	5.44e-05	0.00277	CbGpPWpGaD
Zileuton—Nausea—Triamcinolone—ulcerative colitis	5.42e-05	0.00127	CcSEcCtD
Zileuton—Nausea—Methylprednisolone—ulcerative colitis	5.41e-05	0.00127	CcSEcCtD
Zileuton—Hypersensitivity—Prednisone—ulcerative colitis	5.31e-05	0.00124	CcSEcCtD
Zileuton—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	5.28e-05	0.00269	CbGpPWpGaD
Zileuton—Vomiting—Dexamethasone—ulcerative colitis	5.27e-05	0.00123	CcSEcCtD
Zileuton—Vomiting—Betamethasone—ulcerative colitis	5.27e-05	0.00123	CcSEcCtD
Zileuton—Rash—Betamethasone—ulcerative colitis	5.22e-05	0.00122	CcSEcCtD
Zileuton—Rash—Dexamethasone—ulcerative colitis	5.22e-05	0.00122	CcSEcCtD
Zileuton—Dermatitis—Dexamethasone—ulcerative colitis	5.22e-05	0.00122	CcSEcCtD
Zileuton—Dermatitis—Betamethasone—ulcerative colitis	5.22e-05	0.00122	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—CRP—ulcerative colitis	5.22e-05	0.00265	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	5.21e-05	0.00265	CbGpPWpGaD
Zileuton—CYP3A4—liver—ulcerative colitis	5.21e-05	0.0161	CbGeAlD
Zileuton—Headache—Betamethasone—ulcerative colitis	5.19e-05	0.00121	CcSEcCtD
Zileuton—Headache—Dexamethasone—ulcerative colitis	5.19e-05	0.00121	CcSEcCtD
Zileuton—Pruritus—Prednisone—ulcerative colitis	5.1e-05	0.00119	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.1e-05	0.00259	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CHP1—ulcerative colitis	5.05e-05	0.00256	CbGpPWpGaD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5e-05	0.00254	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—GHRL—ulcerative colitis	4.98e-05	0.00253	CbGpPWpGaD
Zileuton—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	4.98e-05	0.00253	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCR1—ulcerative colitis	4.96e-05	0.00252	CbGpPWpGaD
Zileuton—Diarrhoea—Prednisone—ulcerative colitis	4.93e-05	0.00115	CcSEcCtD
Zileuton—Nausea—Dexamethasone—ulcerative colitis	4.92e-05	0.00115	CcSEcCtD
Zileuton—Nausea—Betamethasone—ulcerative colitis	4.92e-05	0.00115	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	4.87e-05	0.00247	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CALM3—ulcerative colitis	4.82e-05	0.00245	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ICAM1—ulcerative colitis	4.79e-05	0.00244	CbGpPWpGaD
Zileuton—Dizziness—Prednisone—ulcerative colitis	4.77e-05	0.00112	CcSEcCtD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	4.74e-05	0.00241	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	4.73e-05	0.0024	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.73e-05	0.0024	CbGpPWpGaD
Zileuton—Vomiting—Prednisone—ulcerative colitis	4.59e-05	0.00107	CcSEcCtD
Zileuton—UGT1A9—PPARA activates gene expression—PPARG—ulcerative colitis	4.56e-05	0.00232	CbGpPWpGaD
Zileuton—Rash—Prednisone—ulcerative colitis	4.55e-05	0.00106	CcSEcCtD
Zileuton—Dermatitis—Prednisone—ulcerative colitis	4.54e-05	0.00106	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—ADRB2—ulcerative colitis	4.54e-05	0.00231	CbGpPWpGaD
Zileuton—Headache—Prednisone—ulcerative colitis	4.52e-05	0.00106	CcSEcCtD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.51e-05	0.00229	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	4.46e-05	0.00227	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL6—ulcerative colitis	4.39e-05	0.00223	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL20—ulcerative colitis	4.36e-05	0.00221	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—DLD—ulcerative colitis	4.36e-05	0.00221	CbGpPWpGaD
Zileuton—Nausea—Prednisone—ulcerative colitis	4.28e-05	0.001	CcSEcCtD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	4.27e-05	0.00217	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.14e-05	0.0021	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ADRB2—ulcerative colitis	4.12e-05	0.0021	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GNA12—ulcerative colitis	4.1e-05	0.00208	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ALB—ulcerative colitis	4e-05	0.00203	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCR2—ulcerative colitis	3.88e-05	0.00197	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CXCL8—ulcerative colitis	3.88e-05	0.00197	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	3.87e-05	0.00196	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—ADCY5—ulcerative colitis	3.85e-05	0.00196	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS1—ulcerative colitis	3.79e-05	0.00192	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.72e-05	0.00189	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR6—ulcerative colitis	3.65e-05	0.00186	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IFNG—ulcerative colitis	3.65e-05	0.00185	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—RELA—ulcerative colitis	3.6e-05	0.00183	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ADCY5—ulcerative colitis	3.5e-05	0.00178	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—PTGS2—ulcerative colitis	3.5e-05	0.00178	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	3.48e-05	0.00177	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MAML2—ulcerative colitis	3.46e-05	0.00176	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CALM3—ulcerative colitis	3.41e-05	0.00173	CbGpPWpGaD
Zileuton—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	3.31e-05	0.00168	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	3.3e-05	0.00168	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.26e-05	0.00166	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL1B—ulcerative colitis	3.25e-05	0.00165	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTGER4—ulcerative colitis	3.21e-05	0.00163	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	3.08e-05	0.00156	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—NFKB1—ulcerative colitis	3.04e-05	0.00154	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GHRL—ulcerative colitis	2.94e-05	0.0015	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.89e-05	0.00147	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CALM3—ulcerative colitis	2.85e-05	0.00145	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RIPK2—ulcerative colitis	2.81e-05	0.00143	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	2.81e-05	0.00143	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	2.75e-05	0.0014	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	2.72e-05	0.00138	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CHP1—ulcerative colitis	2.68e-05	0.00136	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ABCB1—ulcerative colitis	2.65e-05	0.00135	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	2.64e-05	0.00134	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.51e-05	0.00128	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ADCY5—ulcerative colitis	2.47e-05	0.00126	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.47e-05	0.00126	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	2.46e-05	0.00125	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	2.45e-05	0.00124	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ADRB2—ulcerative colitis	2.44e-05	0.00124	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—JAK2—ulcerative colitis	2.4e-05	0.00122	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	2.4e-05	0.00122	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—ulcerative colitis	2.36e-05	0.0012	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—DLD—ulcerative colitis	2.32e-05	0.00118	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.3e-05	0.00117	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	2.29e-05	0.00116	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL8—ulcerative colitis	2.19e-05	0.00111	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CHP1—ulcerative colitis	2.19e-05	0.00111	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—JAK2—ulcerative colitis	2.18e-05	0.00111	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS1—ulcerative colitis	2.11e-05	0.00107	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2—ulcerative colitis	2.1e-05	0.00107	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.07e-05	0.00105	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	2.07e-05	0.00105	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ADCY5—ulcerative colitis	2.07e-05	0.00105	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—ulcerative colitis	1.99e-05	0.00101	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	1.91e-05	0.00097	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—ulcerative colitis	1.91e-05	0.000968	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—ulcerative colitis	1.9e-05	0.000967	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CALM3—ulcerative colitis	1.9e-05	0.000964	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—DLD—ulcerative colitis	1.89e-05	0.00096	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.85e-05	0.000941	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PPARG—ulcerative colitis	1.84e-05	0.000937	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.81e-05	0.000921	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	1.78e-05	0.000906	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	1.78e-05	0.000906	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ALB—ulcerative colitis	1.66e-05	0.000843	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ABCB1—ulcerative colitis	1.47e-05	0.000749	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—ulcerative colitis	1.45e-05	0.000737	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ADCY5—ulcerative colitis	1.38e-05	0.000699	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—JAK2—ulcerative colitis	1.29e-05	0.000655	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RELA—ulcerative colitis	1.25e-05	0.000634	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.23e-05	0.000623	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—ulcerative colitis	1.18e-05	0.000598	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.15e-05	0.000585	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—ulcerative colitis	1.12e-05	0.000571	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS1—ulcerative colitis	1.12e-05	0.000569	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—ulcerative colitis	1.12e-05	0.000569	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.1e-05	0.00056	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.08e-05	0.000548	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—ulcerative colitis	1.06e-05	0.000541	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NFKB1—ulcerative colitis	1.05e-05	0.000535	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PPARG—ulcerative colitis	1.03e-05	0.000521	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CALM3—ulcerative colitis	1.01e-05	0.000513	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	9.99e-06	0.000508	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—DLD—ulcerative colitis	9.93e-06	0.000505	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CHP1—ulcerative colitis	9.83e-06	0.0005	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.64e-06	0.00049	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—ulcerative colitis	9.46e-06	0.000481	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—ulcerative colitis	9.22e-06	0.000469	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.21e-06	0.000468	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.98e-06	0.000456	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TGFB1—ulcerative colitis	8.77e-06	0.000446	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—DLD—ulcerative colitis	8.48e-06	0.000431	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CALM3—ulcerative colitis	8.22e-06	0.000418	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—ulcerative colitis	8.07e-06	0.00041	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7.86e-06	0.000399	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ABCB1—ulcerative colitis	7.84e-06	0.000399	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CHP1—ulcerative colitis	7.58e-06	0.000386	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ADCY5—ulcerative colitis	7.32e-06	0.000372	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TP53—ulcerative colitis	7.22e-06	0.000367	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—ulcerative colitis	6.61e-06	0.000336	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—DLD—ulcerative colitis	6.55e-06	0.000333	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ABCB1—ulcerative colitis	6.39e-06	0.000325	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ADCY5—ulcerative colitis	5.96e-06	0.000303	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPARG—ulcerative colitis	5.46e-06	0.000277	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.25e-06	0.000267	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—ulcerative colitis	4.91e-06	0.000249	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS1—ulcerative colitis	4.8e-06	0.000244	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.72e-06	0.00024	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.49e-06	0.000228	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPARG—ulcerative colitis	4.45e-06	0.000226	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CALM3—ulcerative colitis	4.32e-06	0.00022	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—ulcerative colitis	4.29e-06	0.000218	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.13e-06	0.00021	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS1—ulcerative colitis	4.1e-06	0.000208	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.03e-06	0.000205	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—ulcerative colitis	4e-06	0.000203	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CALM3—ulcerative colitis	3.69e-06	0.000188	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.53e-06	0.000179	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—ulcerative colitis	3.5e-06	0.000178	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ABCB1—ulcerative colitis	3.36e-06	0.000171	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.17e-06	0.000161	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.13e-06	0.000159	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ABCB1—ulcerative colitis	2.87e-06	0.000146	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.85e-06	0.000145	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ADCY5—ulcerative colitis	2.68e-06	0.000136	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.34e-06	0.000119	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.22e-06	0.000113	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—ulcerative colitis	2.1e-06	0.000107	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.07e-06	0.000105	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARG—ulcerative colitis	2e-06	0.000102	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.84e-06	9.35e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—ulcerative colitis	1.8e-06	9.13e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.57e-06	7.99e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.54e-06	7.84e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—ulcerative colitis	1.39e-06	7.05e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.21e-06	6.17e-05	CbGpPWpGaD
